NUREXONE BIOLOGIC INC (NRX.CA) Stock Earnings & Estimates
Canada - TSX-V:NRX - CA67059R1091 - Common Stock
0.71 CAD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | ||||||||||||
| EBITDA YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -5.535M | -3.624M 34.53% | -4.924M -35.87% | N/A | N/A | |
| EBIT YoY % growth | -70K | -50K 28.57% | -30K 40.00% | -460K -1,433.33% | -110K 76.09% | -90K 18.18% | -60K 33.33% | -130K -116.67% | -5.541M -4,162.31% | -3.657M 34.00% | -5.009M -36.97% | N/A 197.80% | N/A | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A 11.11% | N/A | N/A 25.00% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.02 -3.00% | -0.02 14.17% | -0.02 10.43% | -0.02 14.17% | -0.01 50.00% | -0.01 50.00% |
| Revenue Q2Q % growth | ||||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 3.664M 385.14% | 3.701M 349.39% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.02 -16.50% | -0.02 | 0.00 | -16.50% |
| Q1 2025 Q2Q % growth | -0.02 -15.00% | -0.02 | 0.00 | -11.65% |
| Q4 2024 Q2Q % growth | -0.02 -60.00% | -0.02 | 0.00 | -16.50% |
| Q3 2024 Q2Q % growth | -0.02 23.08% | -0.03 | 0.01 | 35.28% |
| Q2 2024 Q2Q % growth | -3.00% | -0.02 | % | |
| Q1 2024 Q2Q % growth | -0.02 | -0.02 | 0.00 | 2.91% |
| Q4 2023 Q2Q % growth | -0.02 | -0.02 | 0.01 | 27.18% |
| Q3 2023 Q2Q % growth | -0.03 | -0.02 | -0.01 | -26.21% |
| Q2 2023 Q2Q % growth | -0.02 | -0.02 | 0.00 | 2.91% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 0% | -14.29% |
| Revenue | N/A | N/A | N/A | N/A |